| erratum | Q1348305 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1014687269 |
| P356 | DOI | 10.1007/S10354-010-0839-5 |
| P953 | full work available at URL | https://link.springer.com/content/pdf/10.1007/s10354-010-0839-5.pdf |
| http://link.springer.com/article/10.1007/s10354-010-0839-5/fulltext.html | ||
| http://link.springer.com/content/pdf/10.1007/s10354-010-0839-5.pdf | ||
| http://link.springer.com/content/pdf/10.1007/s10354-010-0839-5 | ||
| P698 | PubMed publication ID | 21080269 |
| P5875 | ResearchGate publication ID | 225860379 |
| P2093 | author name string | Christian F. Singer | |
| P2860 | cites work | Journal of Clinical Oncology | Q400292 |
| Untangling the ErbB signalling network | Q27860884 | ||
| A unique structure for epidermal growth factor receptor bound to GW572016 (Lapatinib): relationships among protein conformation, inhibitor off-rate, and receptor activity in tumor cells | Q28282744 | ||
| ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer | Q28678776 | ||
| Vascular endothelial growth factor (VEGF) and its receptors | Q29615390 | ||
| Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex | Q34314489 | ||
| Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma and various other solid tumors | Q36975174 | ||
| Rational combinations of trastuzumab with chemotherapeutic drugs used in the treatment of breast cancer | Q40554269 | ||
| The HER-2-targeting antibodies trastuzumab and pertuzumab synergistically inhibit the survival of breast cancer cells. | Q40571024 | ||
| ErbB-2 amplification inhibits down-regulation and induces constitutive activation of both ErbB-2 and epidermal growth factor receptors. | Q40966152 | ||
| Epidermal growth factor receptor (HER1) tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2/neu (erbB2)-overexpressing breast cancer cells in vitro and in vivo | Q43829350 | ||
| P433 | issue | 19-20 | |
| P407 | language of work or name | German | Q188 |
| P304 | page(s) | 501-505 | |
| P577 | publication date | 2010-08-24 | |
| P1433 | published in | Wiener Medizinische Wochenschrift | Q2568998 |
| P1476 | title | Principles and method of action of targeted therapies | |
| P478 | volume | 160 |
Search more.